Novartis AG
NVS News Today: Stay Updated with the Latest Novartis AG News in Real Time
Find NVS news now at Meyka AI. Stay informed with the latest Novartis AG stocks updates, including price news, market analysis, and expert insights.
NOVN.SW Stock Edges Up 0.15% as Earnings Loom on April 28
Novartis AG (NOVN.SW) trades at CHF116.28 on SIX ahead of April 28 earnings announcement. Meyka AI rates the stock B+.
IMM.AX Stock Surges 1.37% on ASCO Presentation News, 24 Apr 2026
IMM.AX stock rises 1.37% to A$0.074 on ASCO conference presentation announcement. Immutep Limited gains pre-market momentum on clinical trial updates.
NOVN.SW stock falls 2.29% in after-hours trading on April 21
NOVN.SW stock drops 2.29% to CHF116.1 in after-hours trading. Novartis AG shows mixed signals with strong fundamentals but technical weakness.
IMM.AX stock surges 13% on 21 Apr 2026 amid heavy trading
IMM.AX stock jumped 13% to A$0.078 on 21 Apr 2026 with volume reaching 80.5M shares. Immutep Limited faces headwinds despite intraday gains.
BION.SW Stock Earnings Spotlight: BB Biotech AG Heads to CHF46.65 Pre-Market
BB Biotech AG (BION.SW) trades at CHF46.65 with B grade rating. Healthcare biotech fund shows mixed signals ahead of earnings.
DOCM.SW Stock Surges 9.8% on April 20, 2026 as DocMorris Gains
DOCM.SW stock price jumped 9.8% to CHF 7.26 on April 20, 2026. DocMorris AG shows strong trading momentum on SIX exchange.
NVS Novartis AG Earnings Recap: April 27, 2026
Novartis AG earnings recap for April 27, 2026. Stock price at $150.99 with B+ grade from Meyka AI. Healthcare earnings analysis.
NOVN.SW Novartis AG Earnings April 28 – Meyka Grade B+
Novartis AG (NOVN.SW) reports Q1 2026 earnings on April 28. Market cap $226.7B. Meyka AI rates B+. Stock at CHF117.98.
EVE.SW Stock Surges 9% on High Volume Trading April 17
EVE.SW stock jumped 9% to CHF 0.92 on April 17 with strong trading volume. EvoNext Holdings analysis on SIX exchange.